Experience

Davis Polk advised the initial purchaser in connection with a Rule 144A offering by Teladoc, Inc. of $275 million aggregate principal amount of its 3.00% convertible senior notes due 2022…

Davis Polk advised the dealer manager on a cash tender offer by Bristol-Myers Squibb Company for any and all of its 5.875% notes due 2036, 6.125% notes due 2038 and 6.875% debentures due…

Davis Polk advised Hilong Holding Limited on its $250 million Regulation S offering of 7.25% senior notes due 2020. The notes were guaranteed by certain offshore subsidiaries of Hilong. The…

Davis Polk advised the joint global coordinators, joint lead managers and joint bookrunners on a Rule 144A/Regulation S offering of $500 million aggregate principal amount of 5.30…

Davis Polk advised Noble Americas Corp., Noble Petro, Inc. and Noble Americas Gas & Power Corp. in connection with amending and restating their $2 billion asset-based revolving credit…

Davis Polk advised the representatives of the underwriters in connection with an SEC-registered offering by Coach, Inc. of $400 million aggregate principal amount of its 3.000% senior notes…

Davis Polk advised the selling agents in connection with the establishment of General Motors Financial Company, Inc.’s SEC-registered retail medium-term notes program. The program initially…

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A/Regulation S notes offering by Arcor S.A.I.C. of an aggregate principal amount of an…

Davis Polk advised the underwriter in connection with the $341.6 million secondary offering of 9,650,000 shares of common stock of Hilton Grand Vacations Inc. by certain selling…

Davis Polk advised the joint book-running managers in connection with a $260.8 million SEC-registered offering of 3,622,500 shares of common stock of Loxo Oncology, Inc. The common stock is…